Aurobindo Pharma Ltd rises for third straight session

Aurobindo Pharma Ltd is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty Pharma index.

Aurobindo Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.64% on the day, quoting at 23350.8. The Sensex is at 77182.56, up 0.74%. Aurobindo Pharma Ltd has slipped around 4.4% in last one month.

Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has slipped around 1.96% in last one month and is currently quoting at 22061.7, up 0.31% on the day. The volume in the stock stood at 4.31 lakh shares today, compared to the daily average of 11.52 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1197.6, up 1.54% on the day. Aurobindo Pharma Ltd is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty Pharma index.

  • Related Posts

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre

    US FDA launches expedited IND Pilot, begins accepting applications

    US FDA launches expedited IND Pilot, begins accepting applications

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    Ghaziabad: Fake supplement racket busted, 5 held

    Ghaziabad: Fake supplement racket busted, 5 held

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records